Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) has shared an update.
Hangzhou Tigermed Consulting Co., Ltd. announced proposed amendments to its Articles of Association, which were approved by its board of directors and will be submitted for shareholder approval at the 2024 annual general meeting. The amendments aim to expand the company’s business scope and align with relevant Chinese laws and stock exchange regulations, potentially impacting the company’s operational and regulatory framework.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the consulting industry. It is listed on the Hong Kong Stock Exchange and focuses on providing consulting services.
YTD Price Performance: 7.10%
Average Trading Volume: 65
Technical Sentiment Signal: Hold
Current Market Cap: €5.05B
For a thorough assessment of 3347 stock, go to TipRanks’ Stock Analysis page.